Søgeresultat

Er du ikke sundhedsperson? Besøg vores offentlige hjemmeside, klik her

For sundhedspersoner i Danmark

Er du ikke sundhedsperson? Besøg GSK's hjemmeside til offentligheden

Indkøbskurv

Bruger er logget

Rapporter bivirkning

Luk

For sundhedspersoner i Danmark

Kan indeholde produktinformation

Profil aktivere – afventer validering

Din profil er blevet aktiveret. Det er kun sundhedspersoner der kan få adgang til sundhed.gsk.com og vi mangler stadig at validerer de oplysninger du har brugt til at oprette din profil. Så snart dette har fundet sted, sender vi dig en mail

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

Profil aktiveret – afventer validering

Din profil er nu aktiveret, men vi afventer endelig validering. Vi sender dig en e-mail hurtigst muligt med yderligere information.

Event Account activated - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

Anoro Ellipta 20 mcg

er tilføjet din indkøbskurv.

Se indkøbskurv

Popup

ASYEVE0001=Event Registration-Portal
ASYEVE0002=Watched General Video
ASYEVE0003=Watched Virtual Rep Video
ASYEVE0004=Watched Patient Video
ASYEVE0005=Watched Expert Video
ASYEVE0006=Watched Webcast
ASYEVE0007=Downloaded Content-Portal
ASYEVE0008=Clicked to App Store
ASYEVE0009=Watched Learning Module Video
ASYEVE0010=eMail Sent
ASYEVE0011=eMail Read
ASYEVE0012=eMail Clicked
ASYEVE0013=Shared a Link
ASYEVE0014=Rep Request
ASYEVE0015=Joined health.gsk
ASYEVE0016=email Not Sent
ASYEVE0017=Email Not Sent
ASYEVE0018=Email Not Sent
ASYEVE0037=IJSFAID is not available
ASYEVE0038=EMAIL ID and IJSFAID is not available
ASYEVE0039=The user is opted out
ASYEVE0040=Scope IDs are different

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: moder.html

Filter Tags:Event format|Produkt|Terapiområde

Filter Tags values when filtered by all Tags:Alle produkter |Alle terapiområder|Alle indikationer

OutofBox filter category name:Format

Filter Reset all button text:Slet alt

Filter Apply button text:Udfør

Events registration success message: Din registrering er modtaget

Events registration failure message: Registreringsfejl

Events un-registration success message: Du er nu afmeldt

Events un-registration failure message: Afmelding mislykkedes

Reset all default value: Nulstil søgning

Show More Naivagation Values: 10|15|20

Previous Text label: Forrige

Next Text label: Næste

Show Text label: Vis:

Seats left Text: Ledige pladser

No Seats left Text: Ingen Ledige pladser

Text Area Blank copy in Email Template:Ikke udfyldt

Month Names:Januar,Februar,Marts,April,Maj,Juni,Juli,August,September,Oktober,November,December

Day Names:Søn,Ma,Tirs,Ons,Tors,Fre,Lør

Month Names Short:Januar,Februar,Marts,April,Maj,Juni,Juli,August,September,Oktober,November,December

Day Names Short:Søn,Ma,Tirs,Ons,Tors,Fre,Lør

Day Names Min:Søn,Ma,Tirs,Ons,Tors,Fre,Lør

Date Format:dd-mm-yy

Events Filter Date Placeholder:dd-mm-yy

Du forlader nu GSK’s hjemmeside

Ved at klikke på dette link, kommer du til en hjemmeside, som ikke er ejet eller kontrolleret af GSK.

Fortsæt

Gå tilbage

180 {0} - {1} af {2} emner

GSKPro | Landingpage

GSKPro DK - Kun for Sundhedspersoner i Danmark. Kan indeholde produktinformation

https://gskpro.com/da-dk/

COPD Assessment Test (CAT) og Medical Research Council dyspnoea score (MRC) - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-cat-mrc/

COPD - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-copd1/

Patienter med KOL, der er kandidat til trestofbehandling (LABA/LAMA/ICS) - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-trestofbehandling/

COPD - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-copd2/

Patienter med KOL, der bør henvises til et KOL ambulatorie - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-patienter-med-kol-i-kol-amb/

Valg af medicinsk behandling til patienter med KOL - GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/gsktalks-medicinsk-behandling-patienter-kol/

GSK Talks

https://gskpro.com/da-dk/terapiomrader/gsktalks/

GSK Webinars - Charlotte Ulrik

https://gskpro.com/da-dk/terapiomrader/webinars/webinars-ulrik/

GSK nyheder

https://gskpro.com/da-dk/updates-under-development/

Update Password Confirmation

https://gskpro.com/da-dk/login/opdater-adganskode/update-password-confirmation/

Update Password

https://gskpro.com/da-dk/login/opdater-adganskode/

Kontakt lægemiddelkonsulent

https://gskpro.com/da-dk/kontakt-os/anmod-konsulent/

COPD - GSK Talks

https://gskpro.com/da-dk/campaigns/gsktalks/gsktalks-copd1/

COPD - GSK Talks

https://gskpro.com/da-dk/campaigns/gsktalks/gsktalks-copd2/

Søgeresultat

https://gskpro.com/da-dk/search-results/

Danish PIs

IV & SC PIs for Danemark

https://gskpro.com/da-dk/benlysta-belimumab-prescribing-information/

Nucala syringe

https://gskpro.com/da-dk/terapiomrader/nucala-syringe/

GSK Talks

https://gskpro.com/da-dk/campaigns/gsktalks/

Forsendelsesoplysninger

https://gskpro.com/da-dk/profil-detaljer/edit-shipping-details/

Access GSK Page

https://gskpro.com/da-dk/accessgsk-page/

IS Sotrovimab

https://gskpro.com/da-dk/is-sotrovimab/

Xevudy

https://gskpro.com/da-dk/produktsogning/xevudy/

Xevudy learn more

https://gskpro.com/da-dk/external-redirects/xevudy-learn-more/

Sotrovimab

https://gskpro.com/da-dk/sotrovimab/

Vacciner

https://gskpro.com/da-dk/terapiomrader/vaccines/

Skift adgangskode

https://gskpro.com/da-dk/profil-detaljer/skift-adgangskode/

Profil

https://gskpro.com/da-dk/profil-detaljer/

Unsubscribe Success

https://gskpro.com/da-dk/unsubscribe-lite/unsubscribe-success/

Unsubscribe Success

https://gskpro.com/da-dk/unsubscribe/unsubscribe-success/

Success

https://gskpro.com/da-dk/kommunikationspraeferencer/success/

Events

https://gskpro.com/da-dk/events/

Zejula presentation

https://gskpro.com/da-dk/internal-redirects/zejula-presentation/

VOCABRIA▼ (cabotegravir) + REKAMBYS▼ (rilpivirine) Product Information for Healthcare Professionals

Exclusively created for healthcare professionals to provide information, services and support related to VOCABRIA▼ (cabotegravir) + REKAMBYS▼ (rilpivirine)

https://gskpro.com/da-dk/produktsogning/carla/home/

Onkologi

https://gskpro.com/da-dk/terapiomrader/oncology/

Rapportering af mulig bivirkning

https://gskpro.com/da-dk/rapportering-af-mulig-bivirkning/

GSK ONCO TALKS

https://gskpro.com/da-dk/terapiomrader/onco2024/TEMP-onco-talks-updatedTEST/

Vocabria Rekambys

Vocabria Rekambys ATLAS-2M-Study-Design

https://gskpro.com/da-dk/produktsogning/carla/efficacy-and-safety/atlas-2m-study-design/

Efficacy and Safety

https://gskpro.com/da-dk/produktsogning/carla/efficacy-and-safety/

Home

https://gskpro.com/da-dk/produktsogning/carla/

Vocabria-rekambys

Vocabria-rekambys Who to Consider - Patient Reported Challenges

https://gskpro.com/da-dk/produktsogning/carla/who-to-consider/patient-interest-and-needs/

Vocabria Rekambys

Vocabria Rekambys ATLAS-2M-Efficacy

https://gskpro.com/da-dk/produktsogning/carla/efficacy-and-safety/atlas-2m-efficacy/

Who to consider?

https://gskpro.com/da-dk/produktsogning/carla/who-to-consider/

Reset Password

https://gskpro.com/da-dk/login/nulstil-adgangskode/

Glemt adgangskode

Venligst indtast din e-mailadresse, og du vil herefter modtage en e-mail med en midlertidig adgangskode

https://gskpro.com/da-dk/login/glemt-adgangskode/

Vocabria-Rekambys

Vocabria-Rekambys Efficacy and Safety Overview

https://gskpro.com/da-dk/produktsogning/carla/efficacy-and-safety/overview/

Bestil materiale

https://gskpro.com/da-dk/ressourcer/

login-proxy

https://gskpro.com/da-dk/login-proxy/

Login

https://gskpro.com/da-dk/login/logind/

Registration

https://gskpro.com/da-dk/opret-profil/

Nucala fyldt pen

https://gskpro.com/da-dk/terapiomrader/nucala-pen/

Resources

https://gskpro.com/da-dk/internal-redirects/material-library-oncology/

Resources

https://gskpro.com/da-dk/internal-redirects/material-library/

Video - Dovato Tango 144 week study

https://gskpro.com/da-dk/terapiomrader/hiv/dovato-tango-144week-study-video/

GSKTalks - HIV

https://gskpro.com/da-dk/terapiomrader/hiv/hiv-gsktalks/

HIV

https://gskpro.com/da-dk/terapiomrader/hiv/

Safety & Tolerability

DOVATO (dolutegravir/lamivudine): a tolerability profile you expect from DTG and 3TC

https://gskpro.com/da-dk/produktsogning/dovato/safety-tolerability/safety/

Efficacy

The efficacy of DOVATO (dolutegravir/lamivudine): proven in clinical trials and real-world studies

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/efficacy-overview/

Q & A til Vocabria + Rekambys

GSKpro Q & A til Vocabria + Rekambys

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/q-and-a/

VOCABRIA▼ (cabotegravir) + REKAMBYS▼ (rilpivirine) Product Information for Healthcare Professionals

Exclusively created for healthcare professionals to provide information, services and support related to VOCABRIA▼ (cabotegravir) + REKAMBYS▼ (rilpivirine)

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/

KOL

https://gskpro.com/da-dk/terapiomrader/kol/

GSKPro DK | Kontakt

Kontakt

https://gskpro.com/da-dk/terapiomrader/kol/kontakt/

PASO DOBLE

FOR HCPs ONLY: Overview of DOVATO (dolutegravir/lamivudine) across patient types

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/paso-doble/

The TANGO Study

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/the-tango-study/

The STAT Study

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/the-stat-study/

The GEMINI Studies

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/the-gemini-studies/

The SALSA Study

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/the-salsa-study/

Barrier to Resistance

Clinical trials and real-world evidence support the high barrier to resistance of DOVATO (dolutegravir/lamivudine).

https://gskpro.com/da-dk/produktsogning/dovato/high-barrier-to-resistance/

Dosing

https://gskpro.com/da-dk/produktsogning/dovato/dosing-and-drug-interactions/dosing/

Resources to support your patients starting on VOCABRIA + REKAMBYS

Tools and tips to help your patients understand what to expect from VOCABRIA + REKAMBYS and their role in treatment success.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/videos-and-podcasts/

DOVATO (dolutegravir/lamivudine) resources

Watch expert videos and download supplemental materials.

https://gskpro.com/da-dk/produktsogning/dovato/resources/downloads/

Efficacy

https://gskpro.com/da-dk/produktsogning/dovato/efficacy/

Dovato

https://gskpro.com/da-dk/produktsogning/dovato/

Beyond Suppression

https://gskpro.com/da-dk/produktsogning/dovato/beyond-suppression/

Resources

https://gskpro.com/da-dk/produktsogning/dovato/resources/

Safety & Tolerability

https://gskpro.com/da-dk/produktsogning/dovato/safety-tolerability/

Dosing and Drug Interactions

https://gskpro.com/da-dk/produktsogning/dovato/dosing-and-drug-interactions/

Videos & Podcasts

Exclusively created for healthcare professionals to provide information, services and support related to VOCABRIA▼ (cabotegravir) + REKAMBYS▼ (rilpivirine)

https://gskpro.com/da-dk/produktsogning/carla/videos-and-podcasts/

GSK ONCO TALKS

https://gskpro.com/da-dk/terapiomrader/onco2024/onco-talks2/

GSK ONCO TALKS

https://gskpro.com/da-dk/terapiomrader/onco2024/onco-talks/

ONKOLOGY

https://gskpro.com/da-dk/terapiomrader/onco2024/

Onkologi

https://gskpro.com/da-dk/terapiomrader/hiv/forside/onkologi/

Home

https://gskpro.com/da-dk/terapiomrader/hiv/forside/

Vacciner

https://gskpro.com/da-dk/terapiomrader/hiv/forside/Vacciner/

Home

https://gskpro.com/da-dk/terapiomrader/vaccines/forside/

HIV

https://gskpro.com/da-dk/terapiomrader/vaccines/forside/hiv/

Onkologi

https://gskpro.com/da-dk/terapiomrader/vaccines/forside/onkologi/

Shingrix (herpes zoster vaccine recombinant, adjuvanted)

Shingrix ▼ (herpes zoster vaccine recombinant, adjuvanted) information for Healthcare Professionals registered in Ireland.

https://gskpro.com/da-dk/produktsogning/shingrix/

Overview

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/overview/

VOCABRIA + REKAMBYS dosing and drug interactions

Recommended every-2-month dosing schedule, with an optional oral lead-in.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/dosing-and-drug-interactions/

Challenges with daily oral therapy

Recognising People living with HIV who may be experiencing challenges with their daily oral therapy.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/plhiv-experiences/challenges-with-daily-oral-therapy/

People living with HIV experiences - Patient preference

Finding a regimen that your patient prefers.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/plhiv-experiences/patient-preference/

Home

DOVATO (dolutegravir/lamivudine): recommended as an initial regimen for treatment-naïve PLHIV and certain virologically suppressed patients.

https://gskpro.com/da-dk/produktsogning/dovato/home/

Beyond Suppression

DOVATO (dolutegravir/lamivudine) can support healthy living in PLHIV.

https://gskpro.com/da-dk/produktsogning/dovato/beyond-suppression/co-morbidities/

More Health Outcomes

https://gskpro.com/da-dk/produktsogning/dovato/beyond-suppression/more-health-outcomes/

PLHIV Experiences

Learn about the polypharmacy data reported in Wave 2 of the Positive Perspectives study.

https://gskpro.com/da-dk/produktsogning/dovato/people-living-with-hiv-experiences/

Efficacy in the ATLAS-2M trial

Study design and efficacy data for ATLAS-2M, a large, phase IIIb, open-label, non-inferiority study, with data up to 3-years.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/efficacy/atlas-2m/

Efficacy in the SOLAR trial

Study design and efficacy data for SOLAR, the first head-to-head study comparing every-2-month VOCABRIA + REKAMBYS with daily oral therapy.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/efficacy/solar/

Efficacy

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/efficacy/

Safety and tolerability in the ATLAS-2M trial

Understanding safety and tolerability in the ATLAS-2M trial, comparing every-2-month VOCABRIA + REKAMBYS to monthly VOCABRIA + REKAMBYS over 3-years.

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/safety-and-tolerability/atlas-2m/

Overall safety and tolerability profile

Overview of the safety and tolerability profile of VOCABRIA + REKAMBYS

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/safety-and-tolerability/overall-safety-and-tolerability-profile/

Safety and tolerability in the SOLAR trial

Understanding safety and tolerability in the SOLAR trial, comparing every-2-month VOCABRIA + REKAMBYS to daily oral therapy

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/safety-and-tolerability/solar/

Safety-and-tolerability

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/safety-and-tolerability/

plhiv-experiences

https://gskpro.com/da-dk/produktsogning/vocabria-rekambys/plhiv-experiences/

Kommunikationspræferencer

https://gskpro.com/da-dk/kommunikationspraeferencer/

Respiratorisk

https://gskpro.com/da-dk/terapiomrader/vaccines/forside/respiratory/

Respiratoriske sygdomme & allergi

https://gskpro.com/da-dk/terapiomrader/respiratory/

Respiratorisk

https://gskpro.com/da-dk/terapiomrader/hiv/forside/respiratory/

Respiratoriske sygdomme

https://gskpro.com/da-dk/terapiomrader/respiratory/forside/

Onkologi

https://gskpro.com/da-dk/terapiomrader/respiratory/forside/onkologi/

Vacciner

https://gskpro.com/da-dk/terapiomrader/respiratory/forside/Vacciner/

HIV

https://gskpro.com/da-dk/terapiomrader/respiratory/forside/hiv/

GSKPro DK | Anoro Ellipta

Anoro Ellipta

https://gskpro.com/da-dk/terapiomrader/kol/anoro/

Nucala

https://gskpro.com/da-dk/produktsogning/nucala/

GSKPro DK | Hæmatologi | Omjjara

Omjjara

https://gskpro.com/da-dk/produktsogning/omjjara/home/

GSKPro DK | Omjjara | Kontakt os

Kontakt os

https://gskpro.com/da-dk/produktsogning/omjjara/contactus/

GSKPro Landingpage | HIV

GSKPro DK - Kun for Sundhedspersoner i Danmark. Kan indeholde produktinformation

https://gskpro.com/da-dk/terapiomrader/hiv/forside/home/

GSKPro Landingpage | Vacciner

GSKPro DK - Kun for Sundhedspersoner i Danmark. Kan indeholde produktinformation

https://gskpro.com/da-dk/terapiomrader/vaccines/forside/home/

Kontakt os

https://gskpro.com/da-dk/kontakt-os/

GSKPro Landingpage | Respiratoriske sygdomme

GSKPro DK - Kun for Sundhedspersoner i Danmark. Kan indeholde produktinformation

https://gskpro.com/da-dk/terapiomrader/respiratory/forside/home/

GSKPro DK | Podcasts

Nucala, Podcasts 

https://gskpro.com/da-dk/produktsogning/nucala/podcasts/

Omjjara

https://gskpro.com/da-dk/produktsogning/omjjara/

Støtte til patientforeninger

Patientforeninger er patienternes talerør og repræsentanter for den enkelte patient. Vi samarbejder derfor med patientforeningerne om at styrke patienternes stemme.

https://gskpro.com/da-dk/stoette-og-donationer/stoette-til-patientforeninger/

Støtte til hospitalsafdelinger

GSK støtter relevante udviklings- og informationsprojekter på landets hospitaler. Det er en naturlig konsekvens af vores målsætning om at hjælpe mennesker med at kunne mere, få det bedre og leve længere. Herunder kan du se de projekter GSK har støttet siden 2011.

https://gskpro.com/da-dk/stoette-og-donationer/stoette-til-hospitaler/

Ingen resultater for din valgte søgning. Prøv at:

kontrollere stavningen af søgeordet
skrive et andet søgeord
nulstille eller ændre filterindstillingerne (hvis du brugte filtre til denne søgning)